West Pharmaceutical Services (FRA:WPS) EV-to-EBIT : 39.62 (As of May. 04, 2024)

View and export this data going back to 2010. Start your Free Trial

What is West Pharmaceutical Services EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, West Pharmaceutical Services's Enterprise Value is €24,768 Mil. West Pharmaceutical Services's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €625 Mil. Therefore, West Pharmaceutical Services's EV-to-EBIT for today is 39.62.

The historical rank and industry rank for West Pharmaceutical Services's EV-to-EBIT or its related term are showing as below:

FRA:WPS' s EV-to-EBIT Range Over the Past 10 Years
Min: 17.7 Med: 33.56 Max: 61.5
Current: 39.27

During the past 13 years, the highest EV-to-EBIT of West Pharmaceutical Services was 61.50. The lowest was 17.70. And the median was 33.56.

FRA:WPS's EV-to-EBIT is ranked worse than
77.83% of 460 companies
in the Medical Devices & Instruments industry
Industry Median: 20.215 vs FRA:WPS: 39.27

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. West Pharmaceutical Services's Enterprise Value for the quarter that ended in Mar. 2024 was €26,111 Mil. West Pharmaceutical Services's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €625 Mil. West Pharmaceutical Services's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 2.39%.

West Pharmaceutical Services EV-to-EBIT Historical Data

The historical data trend for West Pharmaceutical Services's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

West Pharmaceutical Services EV-to-EBIT Chart

West Pharmaceutical Services Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

36.73

50.49

45.39

24.52

35.84

West Pharmaceutical Services Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															38.21	45.06	40.68	35.84	42.30

Competitive Comparison of West Pharmaceutical Services's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

West Pharmaceutical Services's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where West Pharmaceutical Services's EV-to-EBIT falls into.

West Pharmaceutical Services EV-to-EBIT Calculation

West Pharmaceutical Services's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	24767.748	/	625.111
	=	39.62

West Pharmaceutical Services's current Enterprise Value is €24,768 Mil.
West Pharmaceutical Services's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €625 Mil.

West Pharmaceutical Services (FRA:WPS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

West Pharmaceutical Services's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	625.111	/	26110.616
	=	2.39 %

West Pharmaceutical Services's Enterprise Value for the quarter that ended in Mar. 2024 was €26,111 Mil.
West Pharmaceutical Services's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €625 Mil.

West Pharmaceutical Services EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of West Pharmaceutical Services's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

West Pharmaceutical Services (FRA:WPS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (FRA:WPS) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

WST:USA WPS:Germany

Address

530 Herman O. West Drive, Exton, PA, USA, 19341-0645

Website

https://www.westpharma.com

West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.